Glucose Management Team
The inpatient Glucose Management Team (GMT) at the University of 麻豆传媒高清 Hospital has grown by leaps and bounds since it was started in 2008 by Dr. Boris Draznin. The team includes the following members:
| (Director) | |
| , DNP, MS, RN | |
| , PA-C | , PA-C (APP Co-Lead) |
| , PA-C | , NP, MSN (APP Co-Lead) |
| , PA-C | , CNS, NP, MS |
| , PA-C | , PA-C |
| , PA-C, MPAS | , DNP, MSN |
| Eileen Findlay, PA-C | , NP, MS, BSN |
The mission of the UCHealth Glucose Management Team is to work with patients, clinical teams, nursing and other staff, to achieve good glycemic control and to plan for hospital discharge. Poor glycemic control in the hospital setting is associated with worse clinical outcomes, but management of diabetes and stress hyperglycemia without causing hypoglycemia is complex. There are many changing factors and the need for close monitoring and adjustments.
The Glucose Management Team works with providers and teams across University Hospital. The team is an integral part of maintaining Joint Commission on Accreditation of Healthcare Certificate of Distinction for Inpatient Diabetes Care for UCHealth Anschutz, and maintaining Top Performer status in the Society of Hospital Medicine eQuips Glucometrics Benchmarking Program.
In addition to providing direct patient care through consults and follow-up visits in the hospital, the Glucose Management Team educates fellows, housestaff, and advanced practice fellows and students in inpatient glycemic management, and is involved in clinical research and quality improvement initiatives.
Our Team
Selected Publications
The team has published original research, scholarly reviews, and a guide to inpatient management of hyperglycemia and diabetes. The Glucose Management Team is an integral part of a national consortium to advance diabetes education and research and improve clinical outcomes. (Current team members in bold below.)
Hirsch IB, Draznin B, Buse JB, Raghinaru D, Spanbauer C, Umpierrez GE, Ullal J, Jones MS, Low Wang CC, Spanakis EK, Chao JH, Sibayan J, Kollman C, Zabala ZE, Moazzami B, Reynolds SL, Ferrara W, Fulghum K, Kass A, Armstrong C, Gilani F, Seggelke S, Churchill J, Monye JO, Choe MY, Scott W, Baran JD, Bais R, Khakpour D, Pasquel FJ, Davis GM, Vellanki P, Kershaw EE, Gligorijevic N, Goley A, Garg A, Alexander B, Matson BC, Diner J, Klein KR, Adair WB, Choksi P, Huang M, Vinh J, Singh LG, Beck RW, for the TIGHT RCT Study Group. Results from a Randomized Trial of Intensive Glucose Management 1 Using CGM Versus Usual Care in Hospitalized Adults with Type 2 Diabetes: the TIGHT Study. Diabetes Care 2025;48(1):118-124. doi: 10.2337/dc24-1779. PMID: 39571106.
Ni K, Hawkins RM, Smyth HL, Seggelke SA, Gibbs J, Lindsay MC, Kaizer LK, Low Wang CC. Safety and efficacy of insulins in critically ill patients receiving continuous enteral nutrition. Endocr Pract 2024;30(4):367-371. PMID: 38307456.
Seggelke SA, Ingram CI, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clin Diabetes 2021;9(2):228-232. https://doi.org/10.2337/cd20-0036. PMID: 33986579.
Seggelke SA, Lindsay MC, Hazlett I, Sanagorski R, Eckel RH, Low Wang CC. Cardiovascular safety of antidiabetic drugs in the hospital setting. Curr Diab Rep 2017;17:64. PMID: 28699089.
Draznin B, Wang Y, Seggelke S, Hawkins RM, Gibbs J, Bridenstine M, Rasouli N, Wang CL. Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections. Endocr Pract. 2014 Dec;20(12):1303-8. doi: 10.4158/EP14174.OR. PMID: 25100383.
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014 Feb;42(1):46-51. doi: 10.3810/hp.2014.02.1091. PMID: 24566596.
Draznin B, Gilden J, Golden SH, Inzucchi SE; PRIDE investigators, Baldwin D, Bode BW, Boord JB, Braithwaite SS, Cagliero E, Dungan KM, Falciglia M, Figaro MK, Hirsch IB, Klonoff D, Korytkowski MT, Kosiborod M, Lien LF, Magee MF, Masharani U, Maynard G, McDonnell ME, Moghissi ES, Rasouli N, Rubin DJ, Rushakoff RJ, Sadhu AR, Schwartz S, Seley JJ, Umpierrez GE, Vigersky RA, Low CC, Wexler DJ. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care. 2013 Jul;36(7):1807-14. doi: 10.2337/dc12-2508. PMID: 23801791
Low Wang CC, Draznin B. Practical approach to management of inpatient hyperglycemia in select patient populations. Hosp Pract (1995). 2013 Apr;41(2):45-53. doi: 10.3810/hp.2013.04.1025. Review. PMID: 23680736
Rasouli N, Seggelke S, Gibbs J, Hawkins RM, Casciano ML, Cohlmia E, Taylor-Cousar J, Wang C, Pereira R, Hsia E, Draznin B. Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions. J Diabetes Sci Technol. 2012 Sep 1;6(5):1038-44. PMID: 23063029
Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012 Sep;97(9):3132-7. doi: 10.1210/jc.2012-1244. Epub 2012 Jun 8. PMID: 22685233
Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutr Clin Pract. 2011 Dec;26(6):714-7. doi: 10.1177/0884533611420727. PMID: 22205560
Seggelke SA, Gibbs J, Draznin B. Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. J Hosp Med. 2011 Mar;6(3):175-6. doi: 10.1002/jhm.874. PMID: 21387555
Contact
Dr. Low Wang
DirectorGlucose Management Team